Could targeted drugs spare brain cancer patients from radiation after surgery?
NCT ID NCT07655583
First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times
Summary
This pilot study explores whether people with melanoma or non-small cell lung cancer that has spread to the brain can safely skip stereotactic radiosurgery (focused radiation) after having a brain tumor surgically removed. Instead of radiation, participants receive systemic therapy tailored to their cancer type—such as immune checkpoint inhibitors for melanoma or targeted pills for certain lung cancers. The goal is to see if these drugs alone can prevent the tumor from coming back at the surgical site, potentially avoiding the side effects of radiation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- systemic therapy (immune checkpoint inhibitors for melanoma; osimertinib for EGFR-mutant NSCLC; brigatinib, alectinib, or lorlatinib for ALK-positive NSCLC)
- What this could lead to
- If successful, this approach could allow some patients to avoid brain radiation after surgery, relying instead on targeted drugs or immunotherapy to prevent recurrence.
- What could go wrong
- This is a very small pilot study with only 20 participants, so results may not apply broadly. The cancer could still return in the brain without radiation, and the drugs have their own side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict frailty in serious illness? a large study investigates
- Engineered immune cells take aim at brain tumors
- Study reveals why immunotherapy works differently in liver, lung, and brain tumors
- Could a common pain pill protect the brain during surgery?
- Promising new combo targets hard-to-treat breast cancer brain tumors
- Brain zap aftermath: can we map and avoid memory loss?